FIGURE

Figure 2

ID

ZDB-FIG-221214-129

Publication

Poudel et al., 2022 - Resveratrol-Mediated Reversal of Doxorubicin-Induced Osteoclast Differentiation

Other Figures

All Figure Page

Back to All Figure Page

Figure 2

Resveratrol prevents doxorubicin-induced osteoclast differentiation. RAW 264.7 cells were cultured for 4 days with M-CSF (30 ng/mL) and RANKL (50 ng/mL) and treated with resveratrol (RES) and doxorubicin (DOX) alone or combined. TRAP-positive osteoclastic cells (A). Number of TRAP-positive cells (B). Number nuclei in TRAP-positive cells from the different treatments. Cells were grouped according to the number of nuclei: 1, 2, 3 or more than 4 (≥4) (C). One-way ANOVA, Tukey’s multiple comparisons test, *—p ≤ 0.05, **—p ≤ 0.01, ***—p ≤ 0.001, ****—p ≤ 0.0001.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Int. J. Mol. Sci.